Literature DB >> 7927195

Relationship of some endogenous sex steroid hormones to leukocyte arylsulphatase A activities in pre- and postmenopausal healthy women.

P Oner1, S Bekpinar, F Cinar, A Argun.   

Abstract

This study was planned to investigate whether the physiological variations in endogenous gonadal steroid hormones during fertile period to menopause might affect the Arylsulphatase A (ARS-A) activities in leukocytes in healthy women. In premenopausal women, means of the leukocyte ARS-A activity were significantly highest at ovulatory phase, and lowest at early follicular phase. In contrast, the mean leukocyte ARS-A activity in postmenopausal women was approximately equivalent to the mean leukocyte enzyme in cycling women at early follicular phase in whom the lowest enzymatic activity was observed. The results of our study, therefore, concluded that gonadal steroid released physiologically into the bloodstream might be expected to stimulate the lysosomal system thereby leading to an enhancement in leukocyte ARS-A activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927195     DOI: 10.1055/s-2007-1001688

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Fumie Omotehara; Koichi Yamada; Kenji Mishima; Ichiro Saito; Yoshio Hayashi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

2.  Immune function in healthy adolescents.

Authors:  J A Bartlett; S J Schleifer; M K Demetrikopoulos; B R Delaney; S C Shiflett; S E Keller
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

3.  Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Megumi Watanabe; Masaru Kobayashi; Katsushi Miyazaki; Yoshio Hayashi
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.